Health - Fight Cancer News

Sep 17, 2010 1:01 PM by Bea Karnes, News First 5

FDA opposes new drug over cancer risk

Federal health experts have panned a highly anticipated weight loss pill that was thought to offer a safer way to shed pounds.

The Food and Drug Administration's panel of experts voted 9-5 against Arena Pharmaceuticals' drug lorcaserin, saying a series of unresolved safety questions outweighed the drug's modest benefits.

Panelists raised concerns about cancer risks with the drug after reviewing tumors seen in rats who were tested with the drug. Lorcaserin is one of three drugs racing to be the first new prescription weight loss pill approved by the FDA in more than a decade.

The FDA is not required to follow the panel's advice.

To schedule a cancer screening, contact the Dorcy Cancer Center at St. Mary-Corwin Medical Center in Pueblo.

 

»Comments

Most Popular

Top Videos

1 2 3 4